AT358737B - Verfahren zur herstellung eines antihaemophilen mittels - Google Patents

Verfahren zur herstellung eines antihaemophilen mittels

Info

Publication number
AT358737B
AT358737B AT819476A AT819476A AT358737B AT 358737 B AT358737 B AT 358737B AT 819476 A AT819476 A AT 819476A AT 819476 A AT819476 A AT 819476A AT 358737 B AT358737 B AT 358737B
Authority
AT
Austria
Prior art keywords
haemophilic
agent
producing
haemophilic agent
Prior art date
Application number
AT819476A
Other languages
English (en)
Other versions
ATA819476A (de
Original Assignee
Behringwerke Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke Ag filed Critical Behringwerke Ag
Publication of ATA819476A publication Critical patent/ATA819476A/de
Application granted granted Critical
Publication of AT358737B publication Critical patent/AT358737B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/647—Blood coagulation factors not provided for in a preceding group or according to more than one of the proceeding groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/50—Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/85—Reproductive organs or embryos
    • Y10S530/851—Placenta; amniotic fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Reproductive Health (AREA)
  • Pregnancy & Childbirth (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AT819476A 1975-11-07 1976-11-04 Verfahren zur herstellung eines antihaemophilen mittels AT358737B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2550011A DE2550011C2 (de) 1975-11-07 1975-11-07 Verfahren zur Herstellung eines antihämophilen Mittels

Publications (2)

Publication Number Publication Date
ATA819476A ATA819476A (de) 1980-02-15
AT358737B true AT358737B (de) 1980-09-25

Family

ID=5961172

Family Applications (1)

Application Number Title Priority Date Filing Date
AT819476A AT358737B (de) 1975-11-07 1976-11-04 Verfahren zur herstellung eines antihaemophilen mittels

Country Status (20)

Country Link
US (1) US4067964A (de)
JP (1) JPS6029362B2 (de)
AT (1) AT358737B (de)
AU (1) AU500621B2 (de)
BE (1) BE848111A (de)
CA (1) CA1077393A (de)
CH (1) CH630805A5 (de)
DE (1) DE2550011C2 (de)
DK (1) DK502176A (de)
ES (1) ES452923A1 (de)
FI (1) FI763165A (de)
FR (1) FR2330408A1 (de)
GB (1) GB1563009A (de)
IL (1) IL50847A (de)
IT (1) IT1063617B (de)
LU (1) LU76145A1 (de)
NL (1) NL7612139A (de)
NO (1) NO763776L (de)
SE (1) SE7612396L (de)
ZA (1) ZA766647B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0044343B1 (de) * 1980-01-28 1984-08-22 Baxter Travenol Laboratories, Inc. Prothrombin enthaltende therapeutische zusammensetzungen und verfahren zur herstellung enzymatisch aktiver blutgerinnungsfaktoren aus prothrombin enthaltenden blutfraktionen
US4459288A (en) * 1981-05-11 1984-07-10 Baxter Travenol Laboratories, Inc. Therapeutic blood clotting factor compositions and their use
DE3625090A1 (de) * 1986-07-24 1988-01-28 Behringwerke Ag Mittel zur therapie faktor viii-resistenter haemophilie a und verfahren zu seiner herstellung
CA1339946C (en) * 1987-03-31 1998-07-07 Michael J. Griffith Ultrapurification process for polypeptides
JP2931319B2 (ja) * 1989-03-29 1999-08-09 吉富製薬株式会社 血液凝固第▲ｖｉｉｉ▼因子の製造法
JP3180824B2 (ja) * 1991-08-30 2001-06-25 シスメックス株式会社 血液凝固試薬
JP2004517950A (ja) * 2001-02-05 2004-06-17 ノボ ノルディスク ヘルス ケア アクチェンゲゼルシャフト 第ｖｉｉ因子ポリペプチド及び第ｖｉｉｉ因子ポリペプチドの組合された使用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3862002A (en) * 1962-05-08 1975-01-21 Sanfar Lab Inc Production of physiologically active placental substances
BE713764A (de) * 1967-05-01 1968-09-16 Baxter Travenol Lab
BE787961A (fr) * 1971-08-24 1973-02-26 Behringwerke Ag Procede d'isolement d'une matiere thromboplastique et medicament contenant ladite matiere
DE2262520B2 (de) * 1972-12-20 1979-10-11 Cutter Laboratories Inc., Berkeley, Calif. (V.St.A.) Verfahren zur Herstellung eines lyophilisierten, lagerfähigen Konzentrats aus menschlichem Plasma

Also Published As

Publication number Publication date
NO763776L (de) 1977-05-10
FR2330408A1 (fr) 1977-06-03
JPS5257310A (en) 1977-05-11
AU500621B2 (en) 1979-05-24
NL7612139A (nl) 1977-05-10
DK502176A (da) 1977-05-08
AU1934176A (en) 1978-05-11
DE2550011A1 (de) 1977-05-12
IT1063617B (it) 1985-02-11
DE2550011C2 (de) 1982-11-25
IL50847A (en) 1980-01-31
FI763165A (de) 1977-05-08
GB1563009A (en) 1980-03-19
IL50847A0 (en) 1977-01-31
LU76145A1 (de) 1977-06-03
CA1077393A (en) 1980-05-13
US4067964A (en) 1978-01-10
FR2330408B1 (de) 1980-03-14
CH630805A5 (de) 1982-07-15
SE7612396L (sv) 1977-05-08
BE848111A (fr) 1977-05-09
ATA819476A (de) 1980-02-15
ES452923A1 (es) 1977-11-16
ZA766647B (en) 1977-10-26
JPS6029362B2 (ja) 1985-07-10

Similar Documents

Publication Publication Date Title
AT355947B (de) Verfahren zur herstellung eines oxydischen schleifmittels
DD135445A5 (de) Verfahren zur herstellung eines antibiotischen mittels
DD127901A5 (de) Verfahren zur herstellung von mercaptoazetidin-derivaten
DD133632A5 (de) Verfahren zur herstellung eines intravenoes applizierbaren serumeiweiss-praeparates
AT365657B (de) Verfahren zur herstellung eines extra harten materials
AT347577B (de) Verfahren zur herstellung eines antiviralen mittels
AT339051B (de) Verfahren zur herstellung eines anorganisch-organischen kunststoffes
ATA268678A (de) Verfahren zur herstellung eines isomalto-oligo- saccaridgemisches
AT358737B (de) Verfahren zur herstellung eines antihaemophilen mittels
AT352918B (de) Verfahren zur herstellung neuer histidin- derivate
AT354835B (de) Verfahren zur herstellung eines zusatzfutter- mittels
AT366056B (de) Verfahren zur herstellung eines phosphordichloridothiolats
AT357155B (de) Verfahren zur herstellung neuer imidazol- derivate
AT358821B (de) Kontinuierliches verfahren zur herstellung eines saeuremittels
AT355725B (de) Verfahren zur herstellung stabiler loesungen
AT361639B (de) Verfahren zur herstellung von 5-androsten-17- -on-derivaten
ATA420277A (de) Verfahren zur herstellung eines elektro- magnetischem siliciumstahls
AT362491B (de) Verfahren zur herstellung eines antidepressiv wirksamen pharmazeutischen praeparates
DD130657A5 (de) Verfahren zur herstellung eines azetamid-derivates
DD133672A5 (de) Verfahren zur herstellung eines saeureadditionssalzes
AT365928B (de) Verfahren zur herstellung eines antaziden pharmazeutischen mittels
DD138222A5 (de) Verfahren zur herstellung eines antibiotikums
ATA598378A (de) Verfahren zur herstellung eines pharma- zeutischen blutstillenden mittels
DD124541A1 (de) Verfahren zur herstellung eines pastenfoermigen hydrophobiermittels
AT357174B (de) Verfahren zur herstellung eines asbestdia- phragmas

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee